zopiclone has been researched along with Seizures in 7 studies
zopiclone: S(+)-enantiomer of racemic zopiclone; azabicyclo(4.3.0)nonane; a nonbenzodiazepine; one of the so-called of Z drugs (zopiclone, eszopiclone, zolpidem, and zaleplon) for which there is some correlation with tumors; was term of zopiclone 2004-2007
zopiclone : A pyrrolo[3,4-b]pyrazine compound having a 4-methylpiperazine-1-carboxyl group at the 5-position, a 5-chloropyridin-2-yl group at the 6-position and an oxo-substituent at the 7-position.
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated racemic zopiclone, its (S)- and (R)-enantiomers and a metabolite, (S)-desmethylzopiclone, for their actions on locomotor activity, rotarod performance, the elevated plus maze and the Vogel conflict test of anxiety, and electroconvulsive shock-induced seizures duration." | 3.71 | Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite. ( Carlson, JN; Glick, SD; Haskew, R; Jerussi, TP; Maisonneuve, IM; Wacker, J, 2001) |
| "Furthermore, the patient suffered from convulsion on two occasions following abrupt withdrawal of zopiclone." | 1.28 | Misuse of zopiclone and convulsions during withdrawal. ( Aranko, K; Henriksson, M; Hublin, C; Seppäläinen, AM, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kristensen, Ø | 1 |
| Pasareanu, AR | 1 |
| Belozertsev, IuA | 1 |
| Shchelkanova, OA | 1 |
| Belozertsev, FIu | 1 |
| Iuntsev, SV | 1 |
| Flynn, A | 1 |
| Cox, D | 1 |
| Carlson, JN | 1 |
| Haskew, R | 1 |
| Wacker, J | 1 |
| Maisonneuve, IM | 1 |
| Glick, SD | 1 |
| Jerussi, TP | 1 |
| Aranko, K | 1 |
| Henriksson, M | 1 |
| Hublin, C | 1 |
| Seppäläinen, AM | 1 |
| Piot, O | 1 |
| Betschart, J | 1 |
| Stutzmann, JM | 1 |
| Blanchard, JC | 1 |
| Ueki, S | 1 |
| Watanabe, S | 1 |
| Yamamoto, T | 1 |
| Kataoka, Y | 1 |
| Shibata, S | 1 |
| Shibata, K | 1 |
| Ohta, H | 1 |
| Shimazoe, T | 1 |
| Kawamoto, H | 1 |
7 other studies available for zopiclone and Seizures
| Article | Year |
|---|---|
[Zopiclone and convulsions].
Topics: Adult; Azabicyclo Compounds; Humans; Hypnotics and Sedatives; Male; Piperazines; Seizures; Substance | 2010 |
[Comparative evaluation of the hypnotic drugs under conditions of brain injury].
Topics: Animals; Azabicyclo Compounds; Brain Injuries; Hypnotics and Sedatives; Hypoxia; Injections, Intrape | 2012 |
Dependence on zopiclone.
Topics: Aged; Azabicyclo Compounds; Female; Humans; Hypnotics and Sedatives; Piperazines; Seizures; Sleep In | 2006 |
Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Azabicyclo Compounds; Diazepam; | 2001 |
Misuse of zopiclone and convulsions during withdrawal.
Topics: Adult; Azabicyclo Compounds; Depressive Disorder; Humans; Hypnotics and Sedatives; Male; Piperazines | 1991 |
Cyclopyrrolones, unlike some benzodiazepines, do not induce physical dependence in mice.
Topics: Animals; Azabicyclo Compounds; Carbolines; Convulsants; Diazepam; Disease Models, Animal; Flunitraze | 1990 |
Behavioral and electroencephalographic effects of zopiclone, a cyclopyrrolone derivative.
Topics: 5-Hydroxytryptophan; Aggression; Anesthesia; Animals; Azabicyclo Compounds; Behavior, Animal; Confli | 1987 |